STOCK TITAN

COSCIENS BIOPHARMA INC (CSCIF) Revenue by Year

CSCIF

COSCIENS BIOPHARMA INC generated $7.5M in revenue in fiscal year 2025. This represents a decrease of 21.8% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters COSCIENS BIOPHARMA INC has filed alongside them.

FY2025 annual
Revenue $7.5M
YoY -21.8%
5Y CAGR +15.5%
10Y CAGR +30.0%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CSCIF Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Revenue$7.5M-21.8%$9.6M+34.2%$7.1M-51.0%$14.6M+177.0%$5.3M+44.0%$3.7M+586.5%$532K-98.0%$26.9M+2812.4%$923K+1.3%$911K+67.2%$545K

CSCIF Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Revenue$1.8M-46.8%$1.5M-20.7%$2.7M+17.6%$1.5M-27.1%$3.3M+98.8%$1.9M-4.1%$2.3M+67.9%$2.1M-3.3%$1.7M-85.4%$2.0M+4.9%$1.4M$2.1M+40.3%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More COSCIENS BIOPHARMA INC financials

Frequently Asked Questions

What was COSCIENS BIOPHARMA INC's revenue in fiscal year 2025?

COSCIENS BIOPHARMA INC generated $7.5M in revenue in fiscal year 2025.

How fast is COSCIENS BIOPHARMA INC's revenue growing?

COSCIENS BIOPHARMA INC (CSCIF) revenue fell by 21.8% year over year, from $9.6M to $7.5M in fiscal year 2025.

How has COSCIENS BIOPHARMA INC's revenue changed over the years?

Across the 11 fiscal years this page covers, COSCIENS BIOPHARMA INC (CSCIF) revenue went from $545K in fiscal year 2015 to $7.5M in fiscal year 2025.

COSCIENS BIOPHARMA INC (CSCIF) reported $1.8M in revenue in Q4 2025. This represents a decrease of 46.8% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what COSCIENS BIOPHARMA INC (CSCIF) reported on that line in every period on record.